Search Results Search Sort by RelevanceMost Recent Case and Commentary Aug 2003 Palliative Care for an Infant with Short Bowel Syndrome and Advanced Liver Disease, Commentary 1 Mark Sheldon, PhD Several physicians offer commentary on when it may be ethical to choose to not pursue life-prolonging treatments for terminally ill infants. Virtual Mentor. 2003;5(8):312-314. doi: 10.1001/virtualmentor.2003.5.8.ccas4-0308. Case and Commentary Jul 2024 When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond? Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements. AMA J Ethics. 2024;26(7):E520-526. doi: 10.1001/amajethics.2024.520. Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527. Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Current page 10
Case and Commentary Aug 2003 Palliative Care for an Infant with Short Bowel Syndrome and Advanced Liver Disease, Commentary 1 Mark Sheldon, PhD Several physicians offer commentary on when it may be ethical to choose to not pursue life-prolonging treatments for terminally ill infants. Virtual Mentor. 2003;5(8):312-314. doi: 10.1001/virtualmentor.2003.5.8.ccas4-0308.
Case and Commentary Jul 2024 When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond? Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements. AMA J Ethics. 2024;26(7):E520-526. doi: 10.1001/amajethics.2024.520.
Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527.